MedTrace Logo

Breath Analysis in Lung Fibrosis

NCT02437448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2020-10-05

No results posted yet for this study

Summary

The aim of the study is to answer the question whether a disease specific profile of breath in patients with idiopathic lung fibrosis can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • Swiss National Science Foundation

    collaborator OTHER

  • University of Zurich

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437448 on ClinicalTrials.gov